Famous daily anti-anxiety medication recalled all over US for ‘failed dissolution’
An anti-anxiety medication used by millions of Americans has been recalled by their distributor
3-milligram tablets of Xanax XR, the brand name for the drug alprazolam, sold in 60-tablet bottles were initially recalled by the distributor Viatris.
On Wednesday, April 15, the pills were recalled nationwide in the US after they "failed dissolution specifications," according to the FDA.
The FDA classified the recall as a Class II, indicating that "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
As per PEOPLE magazine, the pills marked as part of lot number 8177156 are impacted by the recall. The medication will be marked with an expiration date of 02/28/2027.
Anyone who has been prescribed the affected pills should stop taking them immediately, and dispose of them safely.
The pills were distributed to patients between August 27, 2024, and May 29, 2025, per the California State Board of Pharmacy.
For anyone unversed, Xanax is typically prescribed to treat symptoms of anxiety associated with several mental health conditions.
As per Cleveland Clinic, the medication, "works by helping your nervous system calm down," and is one of the most commonly prescribed benzodiazepines (a class of anti-anxiety medication) in the U.S.
-
WHO opposes US travel ban on Ebola-affected countries
-
How Trump’s ‘forever chemicals’ rollback could impact drinking water across America
-
Study reveals watermelon may boost heart health and diet quality
-
WHO declares Ebola outbreak emergency in DR Congo
-
Plastic surgeons see rise in AI-generated beauty requests
-
Vitamin B2 may help cancer cells survive, scientists reveals dark side
-
Ebola returns to DR Congo, Africa CDC confirms
-
Hantavirus outbreak: Could it be new pandemic threat like COVID? Experts weigh in
-
Meningitis leaves one dead, others critically ill; Know how it spreads
-
PCOS renamed PMOS: What new diagnosis means for millions of women’s health
-
Endometriosis linked to small increase in birth defect risk in Canadian study
-
Health Canada issues safety warning over baby self-feeding products sold on Amazon
